These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3072558)

  • 41. [Pharmacokinetics and pharmacodynamics of prednisolone following extremely high dosage as prednisolone hemisuccinate].
    Rohdewald VP; Rehder J; Möllmann H; Barth J; Derendorf H
    Arzneimittelforschung; 1987 Feb; 37(2):194-8. PubMed ID: 3580023
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.
    Fisher LE; Ludwig EA; Wald JA; Sloan RR; Middleton E; Jusko WJ
    Clin Pharmacol Ther; 1992 Jun; 51(6):677-88. PubMed ID: 1535301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Simultaneous analysis of methylprednisolone, methylprednisolone succinate, and endogenous corticosterone in rat plasma.
    Mehvar R; Dann RO; Hoganson DA
    J Pharm Biomed Anal; 2000 Jul; 22(6):1015-22. PubMed ID: 10857570
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Two chromatographic methods for the determination of corticosteroids in human biological fluids: pharmacokinetic applications.
    al-Habet SM; Rogers HJ
    J Pharm Sci; 1989 Aug; 78(8):660-6. PubMed ID: 2674406
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Anaphylaxis caused by the sodium succinate ester of hydrocortisone and methylprednisolone.
    Mansfield LE; Ting S; Haverly RW
    J Asthma; 1986; 23(2):81-3. PubMed ID: 3528118
    [No Abstract]   [Full Text] [Related]  

  • 47. [A case of carcinoma of the tongue treated with megadoses of 6-alpha-methylprednisolone hemisuccinate].
    Cozzolino A; Esposito O
    Arch Stomatol (Napoli); 1979; 20(4):607-11. PubMed ID: 400635
    [No Abstract]   [Full Text] [Related]  

  • 48. Pharmacokinetics of methylprednisolone, methylprednisolone sodium succinate, and methylprednisolone acetate in dogs.
    Toutain PL; Koritz GD; Fayolle PM; Alvinerie M
    J Pharm Sci; 1986 Mar; 75(3):251-5. PubMed ID: 3517294
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacodynamics of methylprednisolone phosphate after single intravenous administration to healthy volunteers.
    Derendorf H; Möllmann H; Krieg M; Tunn S; Möllmann C; Barth J; Röthig HJ
    Pharm Res; 1991 Feb; 8(2):263-8. PubMed ID: 2023879
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Kinetics of hydrolysis of dextran-methylprednisolone succinate, a macromolecular prodrug of methylprednisolone, in rat blood and liver lysosomes.
    Mehvar R; Dann RO; Hoganson DA
    J Control Release; 2000 Jul; 68(1):53-61. PubMed ID: 10884579
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anaphylaxis following administration of intravenous methylprednisolone sodium succinate.
    Doezema D
    Am J Emerg Med; 1987 Jan; 5(1):42-4. PubMed ID: 3545244
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anaphylaxis after intravenous methylprednisolone administration.
    Freedman MD; Schocket AL; Chapel N; Gerber JG
    JAMA; 1981 Feb; 245(6):607-8. PubMed ID: 7005481
    [No Abstract]   [Full Text] [Related]  

  • 53. Methylprednisolone sodium succinate in pediatric parenteral nutrition: influence of vehicle injection.
    Gellis C; Sautou-Miranda V; Jarrige JF; Grand-Boyer A; Bleyzac N; Chopineau J
    Clin Nutr; 2004 Aug; 23(4):515-25. PubMed ID: 15297087
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral contraceptive effects on methylprednisolone pharmacokinetics and pharmacodynamics.
    Slayter KL; Ludwig EA; Lew KH; Middleton E; Ferry JJ; Jusko WJ
    Clin Pharmacol Ther; 1996 Mar; 59(3):312-21. PubMed ID: 8653994
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High dose oral methylprednisolone in patients with rheumatoid arthritis: pharmacokinetics and clinical response.
    Hayball PJ; Cosh DG; Ahern MJ; Schultz DW; Roberts-Thomson PJ
    Eur J Clin Pharmacol; 1992; 42(1):85-8. PubMed ID: 1541321
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of acute obstructive renal failure with high-dose methylprednisolone.
    Flombaum CD; Schroy P; Watson R; Vanamee P
    Arch Intern Med; 1986 Jan; 146(1):58-61. PubMed ID: 3510599
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: immunosuppressive effects after in vivo administration to rats.
    Mehvar R; Hoganson DA
    Pharm Res; 2000 Nov; 17(11):1402-7. PubMed ID: 11205734
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of two ester prodrugs of methylprednisolone on early neurologic recovery in a murine closed head injury model.
    Hall ED; Yonkers PA
    J Neurotrauma; 1989; 6(3):163-8. PubMed ID: 2681792
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Pulse methylprednisolone therapy in children with idiopathic thrombocytopenic purpura].
    Ohtsuka Y; Toku Y; Maeda H; Ohmiya A; Mori K; Fukuda T; Yanai M; Tsuji Y
    Rinsho Ketsueki; 1988 Apr; 29(4):488-93. PubMed ID: 3043039
    [No Abstract]   [Full Text] [Related]  

  • 60. [Plasma assays in bolus injections of methylprednisolone in children].
    Perignon F; Pecquinot MA; Lenoir G
    Presse Med; 1984 Nov; 13(41):2522. PubMed ID: 6239250
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.